Choong Ang Vaccine Laboratory Co. Ltd (072020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.55 Billion ≈ $1.05 Million USD) by net assets (₩104.72 Billion ≈ $70.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Choong Ang Vaccine Laboratory Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 072020 current and long-term liabilities for a breakdown of total debt and financial obligations.

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Yatra Online Inc NASDAQ:YTRA	-0.051x
FineMat Applied Materials Co Ltd TW:6698	-0.033x
Park Elektrik Uretim Madencilik Sanayi ve Ticaret AS IS:PRKME	0.007x
Digital Multimedia Technology Co.Ltd KQ:134580	0.112x
Jayant Agro Organics Limited NSE:JAYAGROGN	-0.075x
Fluence Corporation Ltd AU:FLC	-0.541x
Kingstate Electronics TWO:3206	0.095x
Southland Holdings Inc. NYSE MKT:SLND	0.067x

Annual Cash Flow Conversion Efficiency for Choong Ang Vaccine Laboratory Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Choong Ang Vaccine Laboratory Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩103.87 Billion ≈ $70.39 Million	₩13.40 Billion ≈ $9.08 Million	0.129x	+1.35%
2023-12-31	₩99.80 Billion ≈ $67.64 Million	₩12.71 Billion ≈ $8.61 Million	0.127x	+71.24%
2022-12-31	₩95.30 Billion ≈ $64.59 Million	₩7.09 Billion ≈ $4.80 Million	0.074x	-40.02%
2021-12-31	₩92.98 Billion ≈ $63.01 Million	₩11.53 Billion ≈ $7.81 Million	0.124x	+30.51%
2020-12-31	₩87.55 Billion ≈ $59.33 Million	₩8.32 Billion ≈ $5.64 Million	0.095x	-1.15%
2019-12-31	₩86.37 Billion ≈ $58.53 Million	₩8.30 Billion ≈ $5.62 Million	0.096x	+43.06%
2018-12-31	₩85.00 Billion ≈ $57.61 Million	₩5.71 Billion ≈ $3.87 Million	0.067x	-42.55%
2017-12-31	₩64.68 Billion ≈ $43.83 Million	₩7.56 Billion ≈ $5.12 Million	0.117x	-8.46%
2016-12-31	₩60.37 Billion ≈ $40.91 Million	₩7.71 Billion ≈ $5.23 Million	0.128x	-29.41%
2015-12-31	₩54.88 Billion ≈ $37.19 Million	₩9.93 Billion ≈ $6.73 Million	0.181x	+41.03%
2014-12-31	₩51.99 Billion ≈ $35.23 Million	₩6.67 Billion ≈ $4.52 Million	0.128x	--

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$63.93 Million

₩94.34 Billion KRW

Market Cap Rank

#20929 Global

#1291 in Korea

Share Price

₩10080.00

Change (1 day)

-0.59%

52-Week Range

₩8780.00 - ₩10200.00

All Time High

₩30815.73